mynth
← DATABASE
04/2017MajorityLBO

EQT Partners takes majority stake in Colisée

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV €500M–1.5bn

Context

IK Investment Partners, through its IK VIII Fund, reached an agreement with Eurazeo PME and the management team to acquire a majority stake in Colisée. The founding family and management team reinvested alongside IK, ensuring continuity of strategic direction and operational leadership. The investment thesis centres on supporting Colisée's continued growth through selective buy-and-build acquisitions in France and across Europe, as well as the development of innovative services for elderly people.

It is worth noting that the fund Eurazeo took control of Colisée through an LBO in 2014.

Colisée, which reported an EBITDA margin of [members only] in 2017, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, to compare with the average currently observed in the Healthcare & Pharma sector (14.3x in 2026).

-> Deep-dive in Healthcare & Pharma market trends

Target

Colisée is the fourth largest French EHPAD operator, founded in 1976 and chaired by Christine Jeandel. The group operates numerous establishments across France, Spain, Belgium, Italy, and China. Colisée has grown significantly through an active buy-and-build strategy. Colisée is recognised as one of the leading pan-European elderly care platforms, combining a strong French domestic base with meaningful international operations across Southern Europe and Asia.

Ent. Value

€500M–1.5bn

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2017
€250–500M
€50–100M
[members only]
2016
€250–500M
€50–100M
[members only]

Other operations with Colisée

Other operations with Colisée
DateAcquirerTargetCountrySector
09/2020EQT PARTNERSCOLISÉEFRANCENursing Homes
04/2019COLISÉEARMONEABELGIUMNursing Homes
09/2014EURAZEOCOLISÉEFRANCENursing Homes

Other operations with EQT Partners

Other operations with EQT Partners
DateAcquirerTargetCountrySector
10/2026EQT PARTNERSCLEANAWAYAUSTRALIACollection & Recycling
10/2026EQT PARTNERSQIAGENGERMANYDiagnostic Equipment
09/2026EQT PARTNERSMCGILL AND PARTNERSUNITED KINGDOMStrategy & Management
07/2026EQT PARTNERSCOPIA POWERUNITED STATESSolar / PV
07/2026EQT PARTNERSORIKANAUSTRALIAIoT & Connected Objects
06/2026EQT PARTNERSINTERTEKUNITED KINGDOMTIC (Testing, Inspection, Certification)
03/2026EQT PARTNERSKELDA HOLDINGSUNITED KINGDOMWater
07/2025EQT PARTNERSADEVINTA SPAINSPAINE-commerce & Marketplaces
03/2025EQT PARTNERSFORTNOXSWEDENERP, HR & Finance
04/2024EQT PARTNERSOCEA GROUPFRANCEMaintenance

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
06/2017ICG / MANAGEMENT & PRIVATE INVESTORSDOMUSVIFRANCENursing Homes
05/2017BC PARTNERSDENTALPROITALYDental Centers
01/2017PARTNERS GROUP / PSP INVESTMENTSCERBA HEALTHCAREFRANCELabs (Biology)
01/2017MARSVCAUNITED STATESVet Clinics
10/2016DOMUSVISARQUAVITAESPAINNursing Homes
05/2016VCACOMPANION ANIMAL PRACTICESUNITED STATESVet Clinics
03/2016F2I SGR / CIR - COMPAGNIE INDUSTRIALI RIUNITEKOS GROUPITALYNursing Homes
02/2016OMERSFOREFRONT DERMATOLOGYUNITED STATESOutpatient Care
08/2015CINVENSYNLABGERMANYLabs (Biology)
07/2015ANTIN INFRASTRUCTUREAMEDESGERMANYLabs (Biology)

REFERENCES

Valuation range: EV €500M–1.5bn

Revenue range: €250–500M

EBITDA range: €50–100M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Colisée by EQT Partners are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: eqt partners

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Colisée, a French company specialised in Healthcare Facilities, by EQT Partners in 2017, structured as a leveraged buyout (LBO). This followed a prior holding cycle initiated by Eurazeo in September 2014, before ownership was subsequently transferred to EQT Partners in September 2020 (see dedicated deal pages for details).

How was the acquisition of Colisée by EQT Partners valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €500M–1.5bn band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were Colisée’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Colisée generated annual revenue estimated in the €250–500M range and EBITDA in the €50–100M bracket (FY 2017). Detailed financial figures are available to members.

How does the valuation of Colisée compare to benchmarks in the Healthcare & Pharma sector?

With an estimated valuation multiple in the range of 10x - 18x in 2017, the transaction reflects historical valuation standards. By way of comparison, in 2026 companies in the Healthcare & Pharma sector are valued at a multiple of 14.3x EBITDA.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.